common.study.topics.clinical

Experimental Autologous Blood Transfusion in Healthy Adults

common.study.values.description

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

The Purpose of the study is to test the hypothesis that administration of an S-nitrosylating (SNO) agent can improve tissue oxygenation during transfusion of packed red blood cells (RBCs).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - SNO

S-nitrosylating agent (SNO) Inhalation

Drug - Normal Saline

Normal Saline transfusion

Drug - Red Blood Cell

Blood transfusion (RBCs)

participant.views.study.view.additional

participant.views.study.view.scientific-title

Phase 1 Study of S-Nitrosylation Therapy to Improve Tissue Oxygenation During Autologous Blood Transfusion in Healthy Volunteer

common.study.values.clinical-trial-id

NCT03999229

participant.views.study.view.id

bDkKKa